Home > Boards > US Listed > Medical - Drugs > Evofem (EVFM)

I left this around 10.50 on the downfall

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Striker77 Member Profile
 
Followed By 9
Posts 687
Boards Moderated 0
Alias Born 04/05/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 4:12:25 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/30/2020 4:25:58 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/30/2020 4:21:06 PM
Evofem Biosciences to Present at Solebury Trout Virtual Investor Conference PR Newswire (US) - 3/27/2020 8:30:00 AM
Securities Registration (section 12(b)) (8-a12b) Edgar (US Regulatory) - 3/25/2020 5:07:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2020 5:03:13 PM
Evofem Biosciences Adopts Shareholder Rights Agreement PR Newswire (US) - 3/25/2020 5:00:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/12/2020 4:40:37 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/12/2020 4:27:48 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/12/2020 8:12:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2020 8:01:45 AM
Evofem Biosciences Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 3/12/2020 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/9/2020 4:32:23 PM
Evofem Biosciences to Report Fourth Quarter and Year-end 2019 Results and Provide Corporate Update on March 12, 2020 PR Newswire (US) - 3/3/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2020 8:31:09 AM
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors PR Newswire (US) - 2/26/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 2:11:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 2:11:04 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/13/2020 1:47:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/7/2020 4:34:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/7/2020 4:34:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/7/2020 4:34:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/7/2020 4:33:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/7/2020 4:33:10 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/4/2020 1:03:45 PM
Striker77   Wednesday, 03/21/18 10:14:37 PM
Re: None
Post # of 157 
I left this around 10.50 on the downfall after the merger. Still believe in this and looking for a re entry point. This upcoming proxy meeting does not seem promising though. They could vote to add as many as 5.3 mil shares. I would be ticked if I was the PE firm that put 20 mil into this for the merger. Long term I guess, and thats why I am watching. Biotech with promise is a no brainer the next few years.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist